Dr. Nash and TANGO Featured in GEN

June 3, 2022

Genetic Engineering & Biotechnology News published an article about the history of and recent interest in mRNA-based medications, based in part on an interview with Stoke’s Chief Operating and Business Officer, Huw M. Nash, Ph.D.